PT  - JOURNAL ARTICLE
AU  - Todd M Darlington
AU  - Deborah Bilder
AU  - Jubel Morgan
AU  - Leslie Jerominski
AU  - Venkatesh Rajamanickam
AU  - Rob Sargent
AU  - Nicola J Camp
AU  - Hilary H Coon
TI  - High-risk Autism Spectrum Disorder Utah pedigrees: a novel Shared Genomic Segments analysis
AID  - 10.1101/134957
DP  - 2017 Jan 01
TA  - bioRxiv
PG  - 134957
4099  - http://biorxiv.org/content/early/2017/05/09/134957.short
4100  - http://biorxiv.org/content/early/2017/05/09/134957.full
AB  - Progress in gene discovery for Autism Spectrum Disorder (ASD) has been rapid over the past decade, with major successes in validation of risk of predominantly rare, penetrant, de novo and inherited mutations in over 100 genes (de Rubies et al., 2015; Sanders et al., 2015). However, the majority of individuals with ASD diagnoses do not carry a rare, penetrant genetic risk factor. In fact, recent estimates suggest that most of the genetic liability of ASD is due to as yet undiscovered common, less penetrant inherited variation (Gaugler et al., 2014) which is much more difficult to detect. The study of extended, high-risk families adds significant information in our search for these common inherited risk factors. Here, we present results of a new, powerful pedigree analysis method (Shared Genomic Segments—SGS) on three large families from the Utah Autism Research Program. The method improves upon previous methods by allowing for within-family heterogeneity, and identifying exact region boundaries and subsets of cases who share for targeted follow-up analyses. Our SGS analyses identified one genome-wide significant shared segment on chromosome 17 (q21.32, p=1.47x10-8). Additional regions with suggestive evidence were identified on chromosomes 3, 4, 6, 8, 11, 13, 14, 15, and 18. Several of these segments showed evidence of sharing across families. Genes of interest in these regions include ATP8A1, DOCK3, CACNA2D2, ITGB3, AMBRA1, FOLH1, DGKZ, MTHFS, ARNT2, BTN2A2, BTN3A1, BTN3A3, BTN2A1, and BTN1A1. We are exploring multiple other lines of evidence to follow up these implicated regions and genes.